HemOnc Today New York

The latest news from the annual meeting, including video perspective from faculty members and attendees.


Collaboration essential for management of immunotherapy toxicities

March 9, 2018
NEW YORK — Immunotherapy-related toxicities can be identified through careful monitoring and physicians should collaborate with other…
Meeting News

Real-world data can guide decisions about which patients should receive immunotherapy

March 9, 2018
NEW YORK — The pool of patients eligible to receive immunotherapy likely should include many individuals who were excluded from early…
Meeting News

High microsatellite instability, mutation load may predict checkpoint inhibitor response

March 8, 2018
NEW YORK — Pembrolizumab and nivolumab demonstrated considerable activity in patients with tumors with high levels of microsatellite…
Meeting News

Data on apalutamide, enzalutamide offer new insights into treatment of nonmetastatic castration-resistant prostate cancer

March 8, 2018
NEW YORK — Data presented earlier this year on two therapies offered new insights into the treatment of men with nonmetastatic…
Meeting NewsVideo

VIDEO: Changes in standard of care for sentinel node positive melanoma

March 8, 2018
NEW YORK — In this video commentary from HemOnc Today New York, Vernon K. Sondak, MD, discussed changes in the standard of care for patients…
Meeting News

Data emerge on new immunotherapeutic targets for melanoma

March 8, 2018
NEW YORK — Several trials either have been completed or are underway to evaluate new immunotherapeutic targets for patients with melanoma…
Meeting News

Collaboration key to identification, incorporation of biomarkers for immuno-oncology

March 8, 2018
NEW YORK — Both predictive and prognostic biomarkers can influence immuno-oncology treatment, but further research is still needed to determine…
Meeting News

Practical considerations must guide response assessment, toxicity management with immunotherapy

March 8, 2018
NEW YORK — Clinicians who use immunotherapy to treat patients with cancer must keep several practical considerations in mind with regard to…
Meeting News

HemOnc Today New York to highlight advances in immunotherapy, targeted treatments

October 11, 2017
HemOnc Today is pleased to announce plans for a 3-day CME meeting designed to offer expert perspectives and practical insights into the use of…
Meeting NewsVideo

VIDEO: Key takeaways from HemOnc Today Melanoma and Cutaneous Malignancies

April 20, 2017
NEW YORK — Sanjiv S. Agarwala, MD, program director for HemOnc Today Melanoma and Cutaneous Malignancies, provided an overview of key takeaway…